• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.25% Nasdaq Up 0.65%

    Nuvo Pharmaceuticals Inc. (NRI.TO)

    -Toronto
    6.71 Down 0.04(0.59%) 2:27PM EDT
    Prev Close:6.75
    Open:6.66
    Bid:6.70
    Ask:6.75
    1y Target Est:N/A
    Beta:-0.393214
    Earnings Date:Aug 3 - Aug 8 (Est.)
    Day's Range:6.66 - 6.80
    52wk Range:3.32 - 7.14
    Volume:19,188
    Avg Vol (3m):21,178
    Market Cap:77.08M
    P/E (ttm):N/A
    EPS (ttm):-0.75
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in CAD.

    Headlines

    » More Headlines for NRI.TO

    Key Statistics

    Forward P/E (1 yr):7.37
    P/S (ttm):3.12
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :0.79
    Quarterly EPS Est (Jun-16) :0.20
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Nuvo Research Inc. operates as a life sciences company. The company operates through two segments, Nuvo Pharma and Crescita. It offers Pennsaid, a topical non-steroidal anti-inflammatory drug that is used to treat the signs and symptoms of osteoar... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback